Financhill
Buy
70

DHR Quote, Financials, Valuation and Earnings

Last price:
$227.14
Seasonality move :
10.19%
Day range:
$223.77 - $228.88
52-week range:
$171.00 - $258.23
Dividend yield:
0.54%
P/E ratio:
47.02x
P/S ratio:
6.78x
P/B ratio:
3.16x
Volume:
3.8M
Avg. volume:
3.6M
1-year change:
-5.15%
Market cap:
$161.4B
Revenue:
$23.9B
EPS (TTM):
$4.86

Analysts' Opinion

  • Consensus Rating
    Danaher Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 17 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $255.67, Danaher Corp. has an estimated upside of 11.91% from its current price of $228.46.
  • Price Target Downside
    According to analysts, the lowest downside price target is $220.00 representing 3.7% downside risk from its current price of $228.46.

Fair Value

  • According to the consensus of 20 analysts, Danaher Corp. has 11.91% upside to fair value with a price target of $255.67 per share.

DHR vs. S&P 500

  • Over the past 5 trading days, Danaher Corp. has underperformed the S&P 500 by -1.01% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Danaher Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Danaher Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Danaher Corp. reported revenues of $6.1B.

Earnings Growth

  • Danaher Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Danaher Corp. reported earnings per share of $1.27.
Enterprise value:
178B
EV / Invested capital:
2.57x
Price / LTM sales:
6.78x
EV / EBIT:
32.47x
EV / Revenue:
7.34x
PEG ratio (5yr expected):
--
EV / Free cash flow:
35.48x
Price / Operating cash flow:
32.81x
Enterprise value / EBITDA:
22.53x
Gross Profit (TTM):
$15B
Return On Assets:
4.39%
Net Income Margin (TTM):
14.44%
Return On Equity:
6.87%
Return On Invested Capital:
5.07%
Operating Margin:
20.73%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $25.9B $23.7B $24.3B $5.8B $6.1B
Gross Profit $15.2B $14.1B $15B $3.4B $3.6B
Operating Income $6.1B $4.9B $5.5B $958M $1.3B
EBITDA $8.2B $7.1B $7.9B $1.5B $1.9B
Diluted EPS $7.90 $5.24 $4.86 $1.12 $1.27
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $10.8B $14.3B $21.2B $10.1B $9.6B
Total Assets $82.5B $81B $87.7B $80.6B $79.9B
Current Liabilities $7.3B $8B $9.4B $7.3B $6.3B
Total Liabilities $39B $34B $35.3B $29.3B $28.8B
Total Equity $43.5B $47B $52.4B $51.3B $51.1B
Total Debt $23.6B $19.2B $22.1B $17.5B $16.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $8.1B $6.3B $6.3B $1.5B $1.7B
Cash From Investing -$1.9B -$7.3B -$1.5B -$606M -$312M
Cash From Financing $1.1B -$8.9B -$6B -$845M -$2.8B
Free Cash Flow $6.8B $5B $5B $1.2B $1.4B
DHR
Sector
Market Cap
$161.4B
$28.4M
Price % of 52-Week High
88.47%
50.35%
Dividend Yield
0.54%
0%
Shareholder Yield
3.37%
-1.32%
1-Year Price Total Return
-5.15%
-22.19%
Beta (5-Year)
0.892
0.521
Dividend yield:
0.54%
Annualized payout:
$1.08
Payout ratio:
25.15%
Growth streak:
11 years

Technicals

8-day SMA
Sell
Level $227.41
200-day SMA
Buy
Level $202.92
Bollinger Bands (100)
Buy
Level 195.09 - 218.83
Chaikin Money Flow
Buy
Level 2.1B
20-day SMA
Buy
Level $222.33
Relative Strength Index (RSI14)
Buy
Level 59.77
ADX Line
Buy
Level 34.43
Williams %R
Neutral
Level -25.8914
50-day SMA
Buy
Level $214.41
MACD (12, 26)
Buy
Level 3.95
25-day Aroon Oscillator
Buy
Level 44
On Balance Volume
Neutral
Level 2B

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.9063)
Buy
CA Score (Annual)
Level (0.5623)
Buy
Beneish M-Score (Annual)
Level (-2.7337)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.4705)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Stock Forecast FAQ

In the current month, DHR has received 17 Buy ratings 3 Hold ratings, and 0 Sell ratings. The DHR average analyst price target in the past 3 months is $255.67.

  • Where Will Danaher Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Danaher Corp. share price will rise to $255.67 per share over the next 12 months.

  • What Do Analysts Say About Danaher Corp.?

    Analysts are divided on their view about Danaher Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Danaher Corp. is a Sell and believe this share price will drop from its current level to $220.00.

  • What Is Danaher Corp.'s Price Target?

    The price target for Danaher Corp. over the next 1-year time period is forecast to be $255.67 according to 20 Wall Street analysts, 17 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is DHR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Danaher Corp. is a Buy. 17 of 20 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of DHR?

    You can purchase shares of Danaher Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Danaher Corp. shares.

  • What Is The Danaher Corp. Share Price Today?

    Danaher Corp. was last trading at $227.14 per share. This represents the most recent stock quote for Danaher Corp.. Yesterday, Danaher Corp. closed at $228.46 per share.

  • How To Buy Danaher Corp. Stock Online?

    In order to purchase Danaher Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
64
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock